Dáil Éireann Debate, Thursday - 25 June 2015
210. Deputy Caoimhghín Ó Caoláin asked the Minister for Health the full-year savings that would be realised from the immediate introduction of generic substitution for the 60 most commonly used off-patent medications, excluding anti-epileptic drugs, based on reference pricing at 70% below branded equivalent, by cost and by volume. [25666/15]
Amharc ar fhreagraThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for attention and direct reply to you.
If the Deputy has not received a reply from the HSE within 15 working days, will he please contact my Private Office and they will follow up the matter with the HSE.
